Dr Ahlfors does not believe that our "kinder, gentler" recommendations differ substantially from current practice. This is good news, if he is correct. The recommendations probably differ less from current practice than they differ from previous recommendations because many clinicians had already begun to question standard (aggressive) treatment of neonatal jaundice.
Dr Ahlfors also points out, as have we1,2 and others3,4 that serum bilirubin levels are poor predictors of bilirubin toxicity. He therefore questions our use of bilirubin levels as the basis for treatment decisions and suggests instead that we just "admit that we do not know how to manage the condition."
- Copyright © 1993 by the American Academy of Pediatrics